X0508 4 2026-03-01 0001781174 Acrivon Therapeutics, Inc. ACRV 0002022214 Peterson Katharine C/O ACRIVON THERAPEUTICS, INC. 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 false true false false Chief Accounting Officer false Stock Option (Right to Buy) 1.51 2026-03-01 4 A false 31900 0 A 2036-02-29 Common Stock 31900 31900 D Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2027, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date. /s/ Adam D. Levy, Attorney-in-Fact 2026-03-03